Parallel Advisors, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7
-97.2%
4
-95.5%
0.00%
Q2 2023$252
+1160.0%
89
+2125.0%
0.00%
Q1 2023$20
-53.5%
40.0%0.00%
Q4 2022$4340.0%0.00%
Q3 2022$040.0%0.00%
Q2 2022$040.0%0.00%
Q1 2022$040.0%0.00%
Q4 2021$0
-100.0%
4
-91.7%
0.00%
Q3 2021$1,0000.0%480.0%0.00%
Q2 2021$1,0000.0%480.0%0.00%
Q1 2021$1,0000.0%480.0%0.00%
Q4 2020$1,0000.0%480.0%0.00%
Q3 2020$1,000480.0%0.00%
Q2 2020$048
+1100.0%
0.00%
Q1 2020$040.0%0.00%
Q4 2019$040.0%0.00%
Q3 2019$040.0%0.00%
Q2 2019$040.0%0.00%
Q1 2019$040.0%0.00%
Q4 2018$040.0%0.00%
Q3 2018$040.0%0.00%
Q2 2018$0
-100.0%
4
-95.6%
0.00%
Q1 2017$2,000900.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders